Luis António Marques da Costa
AuthID: R-000-9BT
131
TITLE: Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
AUTHORS: Aapro, M; Abrahamsson, PA; Body, JJ; Coleman, RE; Colomer, R; Costa, L; Crino, L; Dirix, L; Gnant, M; Gralow, J; Hadji, P; Hortobagyi, GN; Jonat, W; Lipton, A; Monnier, A; Paterson, AHG; Rizzoli, R; Saad, F; Thuerlimann, B;
PUBLISHED: 2008, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 19, ISSUE: 3
AUTHORS: Aapro, M; Abrahamsson, PA; Body, JJ; Coleman, RE; Colomer, R; Costa, L; Crino, L; Dirix, L; Gnant, M; Gralow, J; Hadji, P; Hortobagyi, GN; Jonat, W; Lipton, A; Monnier, A; Paterson, AHG; Rizzoli, R; Saad, F; Thuerlimann, B;
PUBLISHED: 2008, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 19, ISSUE: 3
132
TITLE: Low molecular weight protein tyrosine phosphatase genetic polymorphism and susceptibility to cancer development Full Text
AUTHORS: Alho, I; Clara C Bicho; Carvalho, R; Da Silva, AP; Costa, L; Bicho, A ;
PUBLISHED: 2008, SOURCE: CANCER GENETICS AND CYTOGENETICS, VOLUME: 181, ISSUE: 1
AUTHORS: Alho, I; Clara C Bicho; Carvalho, R; Da Silva, AP; Costa, L; Bicho, A ;
PUBLISHED: 2008, SOURCE: CANCER GENETICS AND CYTOGENETICS, VOLUME: 181, ISSUE: 1
133
TITLE: RANKL plays a role in migration and invasion of the bone-seeking cell line MDA-MB-231-BO2 and regulates MMP1 and MMP9 expression Full Text
AUTHORS: Casimiro, S; Alho, I; Fernandes, A; Lipton, A; Guise, T; Costa, L;
PUBLISHED: 2008, SOURCE: 7th International Meeting on Cancer Induced Bone Disease in CANCER TREATMENT REVIEWS, VOLUME: 34
AUTHORS: Casimiro, S; Alho, I; Fernandes, A; Lipton, A; Guise, T; Costa, L;
PUBLISHED: 2008, SOURCE: 7th International Meeting on Cancer Induced Bone Disease in CANCER TREATMENT REVIEWS, VOLUME: 34
134
TITLE: Markers of bone turnover (ICTP, NTX) and serum matrix metalloproteinase 1 (MMP1) as prognostic markers in breast cancer patients with bone metastases (BM) treated with bisphosphonates (BP)
AUTHORS: Costa, L; Alho, I; Casimiro, S; Oliveira, AG; Bicho, M; Carvalho, R; Fernandes, A; Ali, S; Leitzel, K; Demers, L; Lipton, A;
PUBLISHED: 2008, SOURCE: CLINICAL & EXPERIMENTAL METASTASIS, VOLUME: 25
AUTHORS: Costa, L; Alho, I; Casimiro, S; Oliveira, AG; Bicho, M; Carvalho, R; Fernandes, A; Ali, S; Leitzel, K; Demers, L; Lipton, A;
PUBLISHED: 2008, SOURCE: CLINICAL & EXPERIMENTAL METASTASIS, VOLUME: 25
INDEXED IN: 
WOS
WOS135
TITLE: Elevated plasma cytokine levels in patients with bone metastasis
AUTHORS: Leitzel, K; Demers, L; Suhail, M; Anderson, M; Kelly, P; Costa, L; Lipton, A;
PUBLISHED: 2008, SOURCE: CLINICAL & EXPERIMENTAL METASTASIS, VOLUME: 25
AUTHORS: Leitzel, K; Demers, L; Suhail, M; Anderson, M; Kelly, P; Costa, L; Lipton, A;
PUBLISHED: 2008, SOURCE: CLINICAL & EXPERIMENTAL METASTASIS, VOLUME: 25
INDEXED IN: WOS
WOS136
TITLE: Bisphosphonates: Reducing the risk of skeletal complications from bone metastasis Full Text
AUTHORS: Costa, L;
PUBLISHED: 2007, SOURCE: BREAST, VOLUME: 16, ISSUE: SUPPL. 3
AUTHORS: Costa, L;
PUBLISHED: 2007, SOURCE: BREAST, VOLUME: 16, ISSUE: SUPPL. 3
137
TITLE: Serum carboxyterminal telopeptide (ICTP) as a prognostic marker in bone metastases (BM) treated with bisphosphonates.
AUTHORS: Costa, L; Carvalho, R; Oliveira, AG; Bicho, M; Fernandes, A; Rodrigues, T; Ali, S; Leitzel, K; Demers, L; Lipton, A;
PUBLISHED: 2006, SOURCE: 42nd Annual Meeting of the American-Society-of-Clinical-Oncology in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 24, ISSUE: 18
AUTHORS: Costa, L; Carvalho, R; Oliveira, AG; Bicho, M; Fernandes, A; Rodrigues, T; Ali, S; Leitzel, K; Demers, L; Lipton, A;
PUBLISHED: 2006, SOURCE: 42nd Annual Meeting of the American-Society-of-Clinical-Oncology in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 24, ISSUE: 18
INDEXED IN: WOS
WOS138
TITLE: Gnotobiotically grown aquatic animals: opportunities to investigate host-microbe interactions Full Text
AUTHORS: Marques, A; Ollevier, F; Verstraete, W; Sorgeloos, P; Bossier, P;
PUBLISHED: 2006, SOURCE: JOURNAL OF APPLIED MICROBIOLOGY, VOLUME: 100, ISSUE: 5
AUTHORS: Marques, A; Ollevier, F; Verstraete, W; Sorgeloos, P; Bossier, P;
PUBLISHED: 2006, SOURCE: JOURNAL OF APPLIED MICROBIOLOGY, VOLUME: 100, ISSUE: 5
139
TITLE: Breast cancer patients without pain are at risk for skeletal-related events (SRES) and may have better outcomes with zoledronic acid compared with pamidronate
AUTHORS: Luis Costa; Yin Miao Chen; Nana Shirina;
PUBLISHED: 2006, SOURCE: 30th Congress of the European-Society-for-Medical-Oncology in ANNALS OF ONCOLOGY, VOLUME: 17
AUTHORS: Luis Costa; Yin Miao Chen; Nana Shirina;
PUBLISHED: 2006, SOURCE: 30th Congress of the European-Society-for-Medical-Oncology in ANNALS OF ONCOLOGY, VOLUME: 17
INDEXED IN: WOS
WOS140
TITLE: Breast cancer patients without pain are at risk for skeletal-related events and may have better outcomes with zoledronic acid compared with pamidronate.
AUTHORS: Costa, L; Chen, YM;
PUBLISHED: 2006, SOURCE: 29th Annual San Antonio Breast Cancer Symposium in BREAST CANCER RESEARCH AND TREATMENT, VOLUME: 100
AUTHORS: Costa, L; Chen, YM;
PUBLISHED: 2006, SOURCE: 29th Annual San Antonio Breast Cancer Symposium in BREAST CANCER RESEARCH AND TREATMENT, VOLUME: 100
INDEXED IN: WOS
WOS